19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
about
Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells.Potent 19-norvitamin D analogs for prostate and liver cancer therapyThe Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialEvaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃Immune regulatory activity of vitamin d3 in head and neck cancerRecent developments of 19-nor-1,25-dihydroxyvitamin D3 analogues.19-Norvitamin D analogs for breast cancer therapy.MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic markerOmega-3 and alpha-tocopherol provide more protection against contaminants in novel feeds for Atlantic salmon (Salmo salar L.) than omega-6 and gamma tocopherolMART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.
P2860
Q34904867-B1192459-3EE3-4809-8E46-95320694857CQ36102797-08B2B328-8741-4FD6-8991-B064CD0327F3Q36488819-B33A1FDA-9AEA-464E-A08E-CCFCB2A39FB7Q36682230-7E8A4267-B48B-434E-AD35-5AB32DA2F2ABQ36847293-5226D310-F02E-4854-B33B-6D1104255BF1Q36906268-FB88761D-CDB7-45EB-8BFC-375DBE6B333EQ37210157-DEE6A019-08A0-4FAE-8C9E-46A3F7731DF4Q37226517-36F1C1C4-F0AF-49EF-A36A-F185574154CEQ38115994-6D8B60C9-B833-4E64-BADB-47CAFE942301Q38445909-2BD4CC4C-2ECA-4F3E-A995-9D48E9E6AD43Q38759640-BFF95164-D562-4EEC-B611-9C96F5D58298Q41581779-EB90B04F-EAB7-4F58-A468-AD1E8C706AFDQ41679663-A113D30E-D7EE-408E-809D-C913547B6DB7Q42004467-13725A37-C695-4D8F-82E5-DAD6B0DB1C13Q49722254-7246F556-8B85-4807-BA25-8906C0D05E54
P2860
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@en
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@nl
type
label
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@en
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@nl
prefLabel
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@en
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@nl
P2093
P1433
P1476
19-Nor-2α-(3-hydroxypropyl)-1α ...... potency in liver cancer cells.
@en
P2093
Atsushi Kittaka
Chun-Nan Yeh
Huang-Yang Chen
Jim-ming Lee
Kun-Chun Chiang
Masashi Takano
Miin-Fu Chen
Tai C Chen
P304
P356
10.1016/J.STEROIDS.2011.08.006
P577
2011-08-25T00:00:00Z